Edit

Expansion Therapeutics

https://www.expansionrx.com/

Last activity: 30.09.2021

Active

Categories: BioTech

We bring transformative therapies to patients with severe RNA-mediated diseases.

Likes

371

Mentions

Location: El Salvador, Departamento de La Libertad, San Diego

Employees: 11-50

Total raised: $135.3M

Founded date: 2016

Facebook

Instagram

Investors 2

Date	Name	Website
-	5AM Ventur...	5amventure...
-	RA Capital...	racap.com

Funding Rounds 2

Date	Series	Amount	Investors
30.09.2021	Series B	$80M	-
04.01.2018	Series A	$55.3M	5AM Ventur...

Mentions in press and media 21

Date	Title	Description
30.09.2021	OZY learns that yes, it can get so much worse	This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Earlier this week, the New York Times published a bizarre story about OZY, the media startup back...
30.09.2021	VC Daily : Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs	Good day. Biotechnology startup Expansion Therapeutics Inc. has collected $80 million to hunt for oral medicines that make a significant impact on neurodegenerative diseases. Conventionally, medications have targeted disease proteins. Bosto...
30.09.2021	VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs	Good day. Biotechnology startup Expansion Therapeutics Inc. has collected $80 million to hunt for oral medicines that make a significant impact on neurodegenerative diseases. Conventionally, medications have targeted disease proteins. Bosto...
30.09.2021	VC Daily : Expansion Therapeutics Gets $80 Million -2-	How exploiting a protective gene mutation might protect the brain from Alzheimer's disease. (Fierce Biotech) (END) Dow Jones Newswires 09-30-21 1039ET
29.09.2021	Expansion Therapeutics Raises $80M in Series B Financing	Expansion Therapeutics, Inc., a Boston, MA-based biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, closed an $80m Series B financing. The round was led by Cormorant Asset Management ...
29.09.2021	Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases	Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the close of an $80 million Series B financing. Cormorant Asset Management led the f...
29.09.2021	Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases	-
29.09.2021	Expansion Therapeutics Raises $80M Series B	BOSTON, MA, Expansion Therapeutics, a biotechnology company, has closed an $80 million Series B financing led by Cormorant Asset Management. >> Click here for more funding data on Expansion Therapeutics >> To export Expansio...
14.05.2019	Online Luggage Retailer Away Lands $1.4 Billion Valuation as It Plots Expansion	-
10.09.2018	BIODESY ANNOUNCES NEW CEO AND $20 MILLION SERIES C FINANCING TO ACCELERATE EXPANSION INTO BIOTHERAPEUTICS DISCOVERY AND DEVELOPMENT MARKET	-
04.01.2018	EXPANSION THERAPEUTICS RAISES $55.3 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NOVEL RNA TARGETED SMALL MOLECULE MEDICINES TO TREAT RARE DISEASES	-
03.01.2018	Term Sheet — Wednesday, January 3	5 Qs WITH A DEALMAKER Eric Hippeau, a managing partner at Lerer Hippeau Ventures, is well-known in the venture community for his firm’s blockbuster investments including Birchbox, BuzzFeed, Casper, and Warby Parker. Two thirds of Lerer Hipp...
03.01.2018	EXPANSION THERAPEUTICS RAISES $55.3 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NOVEL RNA TARGETED SMALL MOLECULE MEDICINES TO TREAT RARE DISEASES	-
03.01.2018	Expansion Therapeutics Inks $55.3M in Series A	SAN DIEGO, CA, Expansion Therapeutics announced today the close of a $55.3M Series A financing co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. >> Click here for more funding data on Expansion Th...
03.01.2018	5AM Ventures Joins $55.3M Series A for Expansion Therapeutics	SAN DIEGO--(BUSINESS WIRE)--Expansion Therapeutics, Inc., a new 5AM Ventures formed private company focused on the discovery and development of ribonucleic acid (RNA) targeted small molecule medicines, announced today the close of a $55.3 m...
03.01.2018	Expansion Therapeutics Raises $55.3M in Series A	-
03.01.2018	Expansion Therapeutics Closes $55.3M Series A Financing	Expansion Therapeutics, Inc., a Jupiter, Florida, and San Diego, CA-based new 5AM Ventures formed private company focused on the discovery and development of ribonucleic acid (RNA) targeted small molecule medicines, closed a $55.3m Series A...
03.01.2018	Expansion Therapeutics Finds $55.3M	San Diego-based Expansion Therapeutics, a new biotech startup focused on the discovery and development of ribonucleic acid (RNA) targeted small molecule medicines, said today that it has raised $55.3M in a Series A funding round. The fundin...
03.05.2016	From Mouse to Unicorn: Age of Learning Raises $150M at $1B Valuation, Eyes Expansion Into Schools	Can one app be worth a billion dollars? Age of Learning, a developer of online instructional materials and games for young children, has raised $150 million at a $1 billion valuation, first reported by TechCrunch. The Glendale, CA-based com...
16.03.2015	Pinterest raises $367M at $11B valuation with a look toward international expansion	Pinterest, that company that lets millions of people “pin” pictures and other content to “boards,” has raised $367 million in a new funding round that could be as large as $577.9 million. Pinterest has raised the new money at an $11 billion...
-	Expansion Therapeutics	“HOME”

Expansion Therapeutics

Investors 2

Funding Rounds 2

Mentions in press and media 21

Reviews 0